
Cystic fibrosis drug halts lung damage in young children
9 June 2017
Orkambi targets the most common mutation for cystic fibrosis, but is not available in the UK on the NHS. Now a trial has shown promising effects in children

9 June 2017
Orkambi targets the most common mutation for cystic fibrosis, but is not available in the UK on the NHS. Now a trial has shown promising effects in children

7 June 2017
A hatchling exquisitely preserved in amber is giving us the best glimpse yet of what an extinct group of birds was like